Related Experiment Video

Updated: May 28, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses

John Goulding1, Vikas Tahiliani, Shahram Salek-Ardakani

  • 1Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, San Diego, CA, USA.

Immunological Reviews
|October 25, 2011
PubMed

Insights

New research explores using OX40 (CD134) and OX40L (CD252) to improve CD8(+) T-cell vaccines against respiratory viruses. These molecules show promise in enhancing mucosal immunity for better long-term protection.

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Respiratory viral infections cause millions of deaths annually, necessitating vaccine development.
  • Current vaccines often fail to induce durable CD8(+) T-cell immunity, a crucial component of antiviral defense.
  • Mucosal immunity, particularly at respiratory surfaces, is vital for protection against airborne pathogens.

Purpose of the Study:

  • To review recent findings on OX40 (CD134) and OX40L (CD252) in T-cell mediated immunity.
  • To highlight the potential of OX40/OX40L as adjuvants for enhancing CD8(+) T-cell responses.
  • To focus on their application in poxvirus-based vaccines for respiratory viral infections.

Main Methods:

  • Review of existing literature on costimulatory pathways and mucosal immunity.
  • Analysis of studies investigating OX40 (CD134) and OX40L (CD252) in animal models.
  • Evaluation of the role of these molecules in CD8(+) T-cell generation and memory.

Main Results:

  • OX40 (CD134) and OX40L (CD252) are key costimulatory molecules crucial for CD8(+) T-cell responses.
  • These molecules play a significant role in generating protective immunity at mucosal sites like the lung.
  • Animal models demonstrate impressive results in enhancing T-cell mediated immunity via OX40/OX40L.

Conclusions:

  • Targeting OX40/OX40L pathways offers a promising strategy to improve vaccine efficacy.
  • OX40 (CD134) and OX40L (CD252) hold potential as immunological adjuvants.
  • Enhancing CD8(+) T-cell immunity via these costimulatory molecules could lead to more effective vaccines against respiratory viruses, including poxviruses.

More Related Videos

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...